ConductScience.org, home

Paper36285486

Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction.

Russ A and 8 others. EMBO Rep, 2022. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction. Papers, record 36285486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36285486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction.
PubMed
Journal
EMBO Rep
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
2.78
iCite
Revised in PubMed
2023-01-14
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Russ AAlina
2Wittmann SSabine
3Tsukamoto YYuta
4Herrmann AAlexandra
5Deutschmann JJaninahttps://orcid.org/0000-0002-3162-5789
6Lagisquet JJustine
7Ensser AArmin
8Kato HHirokihttps://orcid.org/0000-0002-9571-4895
9Gramberg TThomashttps://orcid.org/0000-0001-5507-6721

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SARS-CoV-2Major topic
COVID-19Major topic
Humans
RNA
Methyltransferases
RNA-Binding Proteins
Adaptor Proteins, Signal Transducing

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124098121Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA.PLoS Pathog2013https://conductscience.org/library/papers/24098121PubMed
232709887Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.Nat Commun2020https://conductscience.org/library/papers/32709887PubMed
321217758Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5.Nat Immunol2011https://conductscience.org/library/papers/21217758PubMed
424478444Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.J Virol2014https://conductscience.org/library/papers/24478444PubMed
526187414A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2'O-Methylated Self RNA.Immunity2015https://conductscience.org/library/papers/26187414PubMed
624909568IFIT1: A dual sensor and effector molecule that detects non-2'-O methylated viral RNA and inhibits its translation.Cytokine Growth Factor Rev2014https://conductscience.org/library/papers/24909568PubMed
727317694mRNA capping: biological functions and applications.Nucleic Acids Res2016https://conductscience.org/library/papers/27317694PubMed
835833542Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2'-O-ribose methyltransferases.EMBO J2022https://conductscience.org/library/papers/35833542PubMed
934786565All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses.Curr Res Virol Sci2021https://conductscience.org/library/papers/34786565PubMed
10170385905'-Triphosphate RNA is the ligand for RIG-I.Science2006https://conductscience.org/library/papers/17038590PubMed
1127096317Recognition of Endogenous Nucleic Acids by the Innate Immune System.Immunity2016https://conductscience.org/library/papers/27096317PubMed
1221956912Enzymology of RNA cap synthesis.Wiley Interdiscip Rev RNA2010https://conductscience.org/library/papers/21956912PubMed
1334078893A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2'-O methylation of its first nucleotide.Nat Commun2021https://conductscience.org/library/papers/34078893PubMed
1433976430RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells.Nat Immunol2021https://conductscience.org/library/papers/33976430PubMed
1532330414The Architecture of SARS-CoV-2 Transcriptome.Cell2020https://conductscience.org/library/papers/32330414PubMed
1618591409Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5.J Exp Med2008https://conductscience.org/library/papers/18591409PubMed
1734101213SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.EMBO J2021https://conductscience.org/library/papers/34101213PubMed
18210851812'-O methylation of the viral mRNA cap evades host restriction by IFIT family members.Nature2010https://conductscience.org/library/papers/21085181PubMed
1934355795A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model.Eur J Immunol2022https://conductscience.org/library/papers/34355795PubMed
2033514628SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells.J Virol2021https://conductscience.org/library/papers/33514628PubMed

See all 34 referencesDownload CSV of references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
42160380Redundant and distinct mechanisms suppress innate immune activation during SARS-CoV-2 infection.PLoS Biol2026https://conductscience.org/library/papers/42160380PubMed
42037394Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42037394PubMed
42018583Live attenuated vaccination protects aged chimeric ACE2 mice from severe SARS-CoV-2 pathogenicity in vivo.PLoS Pathog2026https://conductscience.org/library/papers/42018583PubMed
41871251Inhibition of coronaviral exoribonuclease activity by TRIM-mediated SUMOylation.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41871251PubMed
41789918The EP424R protein of African swine fever virus functions as a 2'-O-methyltransferase and plays an important role in viral replication.mBio2026https://conductscience.org/library/papers/41789918PubMed
41568342S‑Adenosylhomocysteine Analogs Selectively Suppress Pan-Coronavirus Replication by Inhibition of nsp14 Methyltransferase.ACS Med Chem Lett2026https://conductscience.org/library/papers/41568342PubMed
41472136A Comprehensive View on the Mechanisms of Coronavirus Escaping Innate Immunity.Vet Sci2025https://conductscience.org/library/papers/41472136PubMed
41390777Adenoviral vector oropharyngeal spray immunization elicits mucosal immunity and protects against heterologous SARS-CoV-2 infection.NPJ Vaccines2025https://conductscience.org/library/papers/41390777PubMed
41080534Mechanism by which porcine transmissible gastroenteritis virus disrupts host innate immunity.Front Immunol2025https://conductscience.org/library/papers/41080534PubMed
41004586Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV.Sci Adv2025https://conductscience.org/library/papers/41004586PubMed
40875735Identification of potent antibacterial inhibitors targeting methyltransferase Mtr1/TrmD in Haemophilus influenzae via molecular dynamics simulations.PLoS One2025https://conductscience.org/library/papers/40875735PubMed
40686860Antisense oligonucleotides targeting the SARS-CoV-2 nucleocapsid gene decrease viral titers in hamsters.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40686860PubMed
40358464SARS-CoV-2 nsp16 is regulated by host E3 ubiquitin ligases, UBR5 and MARCHF7.Elife2025https://conductscience.org/library/papers/40358464PubMed
40285011Impact of SARS-CoV-2 Wuhan and Omicron Variant Proteins on Type I Interferon Response.Viruses2025https://conductscience.org/library/papers/40285011PubMed
40220753Structural insights into the assembly and regulation of 2'-O RNA methylation by SARS-CoV-2 nsp16/nsp10.Structure2025https://conductscience.org/library/papers/40220753PubMed
40203104Effective recognition of double-stranded RNA does not require activation of cellular inflammation.Sci Adv2025https://conductscience.org/library/papers/40203104PubMed
40132472A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3a.EBioMedicine2025https://conductscience.org/library/papers/40132472PubMed
39836705Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion.PLoS Biol2025https://conductscience.org/library/papers/39836705PubMed
39643445An MST-based assay reveals new binding preferences of IFIT1 for canonically and noncanonically capped RNAs.RNA2025https://conductscience.org/library/papers/39643445PubMed
39478665Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition.J Med Chem2024https://conductscience.org/library/papers/39478665PubMed

See all 34 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
PDB6W4H

Source PDB

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36285486

GET https://conductscience.org/api/papers/v1/36285486/references?page=2